Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Raised circulating levels of interleukin-6 in women with an intrauterine contraceptive device.

Woolley JA, Seleem S, Hills FA, Salem H, el-Nashar E, Chard T.

Gynecol Obstet Invest. 1996;42(4):241-3.

PMID:
8979095
3.

The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.

Chen JH, Wu SC, Shao WQ, Zou MH, Hu J, Cong L, Miao L, Wang C, Dong J, Gao J, Xiao BL.

Contraception. 1998 Jun;57(6):371-9.

PMID:
9693396
4.
6.

Intrauterine devices: an effective alternative to oral hormonal contraception.

[No authors listed]

Prescrire Int. 2009 Jun;18(101):125-30.

PMID:
19637436
7.

The localization and concentration of copper in the fallopian tube in women with or without an intrauterine contraceptive device.

Wollen AL, Sandvei R, Skare A, Justesen NP.

Acta Obstet Gynecol Scand. 1994 Mar;73(3):195-9.

PMID:
8122497
8.

Microbial and cytopathological study of intrauterine contraceptive device users.

Agarwal K, Sharma U, Acharya V.

Indian J Med Sci. 2004 Sep;58(9):394-9.

PMID:
15470281
9.

Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay.

Wilcox AJ, Weinberg CR, Armstrong EG, Canfield RE.

Fertil Steril. 1987 Feb;47(2):265-9.

PMID:
3817172
10.

Twelve-month comparative multicenter study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand.

Reinprayoon D, Gilmore C, Farr G, Amatya R.

Contraception. 1998 Oct;58(4):201-6.

PMID:
9865999
11.

Candidiasis in women fitted with an intrauterine contraceptive device.

Parewijck W, Claeys G, Thiery M, van Kets H.

Br J Obstet Gynaecol. 1988 Apr;95(4):408-10.

PMID:
3382616
12.

Endometrial lysosomal enzyme activity in ovulatory dysfunctional uterine bleeding, IUCD users and post-partum women.

Wang IY, Fraser IS, Barsamian SP, Manconi F, Street DJ, Cornillie FJ, Russell P.

Mol Hum Reprod. 2000 Mar;6(3):258-63.

PMID:
10694274
13.

Doppler study of the uterine artery in patients using an intrauterine contraceptive device.

Momtaz M, Zayed M, Rashid K, Idriss O.

Ultrasound Obstet Gynecol. 1994 May 1;4(3):231-4.

14.

[Disease and contraception. Recent aspects].

Rozenbaum H.

Contracept Fertil Sex (Paris). 1985 Jan;13(1 Suppl):431-6. French.

PMID:
12280211
15.

Specific serum protein levels in women using intrauterine contraceptive device.

Wiedermann D, Kríz J, Cídl K.

Czech Med. 1980;3(3):239-47.

PMID:
6969168
16.

[Effects of long-term installation of intrauterine devices on intrauterine microenvironment].

Dong BH, Hou GH, Zhang YZ, Fan J, Zhang P, Li L, Luo X.

Zhonghua Yi Xue Za Zhi. 2003 May 25;83(10):823-6. Chinese.

PMID:
12895331
17.

Intrauterine device use and endometrial cancer risk.

Sturgeon SR, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR.

Int J Epidemiol. 1997 Jun;26(3):496-500.

PMID:
9222773
18.

IUD-induced uterine bleeding.

El-badrawi HH, Hafez ES.

Contracept Deliv Syst. 1980 Oct;1(4):303-18.

PMID:
12262133
19.
20.

Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.

Sivin I, Díaz S, Croxatto HB, Miranda P, Shaaban M, Sayed EH, Xiao B, Wu SC, Du M, Alvarez F, Brache V, Basnayake S, McCarthy T, Lacarra M, Mishell DR Jr, Koetsawang S, Stern J, Jackanicz T.

Contraception. 1997 Apr;55(4):225-32.

PMID:
9179454

Supplemental Content

Support Center